INCREASED EXPRESSION OF PLATELET-DERIVED GROWTH-FACTOR TYPE-B RECEPTORS IN THE SKIN OF PATIENTS WITH SYSTEMIC-SCLEROSIS

被引:93
作者
KLARESKOG, L
GUSTAFSSON, R
SCHEYNIUS, A
HALLGREN, R
机构
[1] UNIV UPPSALA,CTR BIOMED,DEPT MED & PHYSIOL CHEM,S-75123 UPPSALA,SWEDEN
[2] KAROLINSKA INST,DEPT CLIN IMMUNOL,S-10401 STOCKHOLM 60,SWEDEN
来源
ARTHRITIS AND RHEUMATISM | 1990年 / 33卷 / 10期
关键词
D O I
10.1002/art.1780331011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The expression of B‐type receptors for platelet‐derived growth factor (PDGF) was investigated in skin biopsy samples from patients with systemic sclerosis (SSc), by immunohistochemical staining using monoclonal antibodies specific for the receptor. Whereas skin from healthy individuals lacked expression of PDGF‐B receptors, receptor expression was seen in sclerodermatous skin lesions from 13 of 14 patients. Increased receptor expression was observed in dermal vessels, as well as on many stromal fibroblast‐like cells close to these vessels. PDGF‐B receptor expression was most pronounced within and around dermal vessels in which perivascular infiltrates of Leu‐4‐positive T lymphocytes and HLA‐DR‐positive, RFD7‐positive activated macrophages were present. Both perivascular inflammatory cell infiltrates and PDGF‐B receptor expression were generally also seen in macroscopically normal areas of the skin of the SSc patients, indicating that the observed phenotypic alterations may precede the macroscopically observable features of scleroderma in the skin. The observed induction of PDGF‐B receptors, together with indirect indications of increased synthesis and release of PDGF, would be compatible with altered PDGF‐mediated control of connective tissue cell growth as part of the molecular basis for development of the skin lesions in SSc. Copyright © 1990 American College of Rheumatology
引用
收藏
页码:1534 / 1541
页数:8
相关论文
共 31 条
[1]  
ANDREWS BS, 1986, J RHEUMATOL, V13, P341
[2]  
BLACK C, 1986, J RHEUMATOL, V13, P1059
[3]  
BLACK CM, 1984, BRIT J RHEUMATOL, V23, P267
[4]   A STRONG ASSOCIATION BETWEEN NULL ALLELES AT THE C4A LOCUS IN THE MAJOR HISTOCOMPATIBILITY COMPLEX AND SYSTEMIC-SCLEROSIS [J].
BRIGGS, DC ;
WELSH, K ;
PEREIRA, RS ;
BLACK, CM .
ARTHRITIS AND RHEUMATISM, 1986, 29 (10) :1274-1277
[5]   RAISED SERUM HYALURONATE LEVELS IN SCLERODERMA - AN EFFECT OF GROWTH-FACTOR INDUCED ACTIVATION OF CONNECTIVE-TISSUE CELLS [J].
ENGSTROMLAURENT, A ;
FELTELIUS, N ;
HALLGREN, R ;
WASTESON, A .
ANNALS OF THE RHEUMATIC DISEASES, 1985, 44 (09) :614-620
[6]  
FITHIAN E, 1981, P NATL ACAD SCI USA, V78, P1791
[7]   CELLULAR INFILTRATES IN SCLERODERMA SKIN [J].
FLEISCHMAJER, R ;
PERLISH, JS ;
REEVES, JRT .
ARTHRITIS AND RHEUMATISM, 1977, 20 (04) :975-984
[8]   2 CLASSES OF PDGF RECEPTOR RECOGNIZE DIFFERENT ISOFORMS OF PDGF [J].
HART, CE ;
FORSTROM, JW ;
KELLY, JD ;
SEIFERT, RA ;
SMITH, RA ;
ROSS, R ;
MURRAY, MJ ;
BOWENPOPE, DF .
SCIENCE, 1988, 240 (4858) :1529-1531
[9]   THE IMMUNOPATHOLOGY OF PROGRESSIVE SYSTEMIC-SCLEROSIS (PSS) [J].
HAYNES, DC ;
GERSHWIN, ME .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1982, 11 (03) :331-351
[10]   PLATELET-DERIVED GROWTH-FACTOR [J].
HELDIN, CH ;
WASTESON, A ;
WESTERMARK, B .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1985, 39 (03) :169-187